US FDA Adcomm Reform: Does Listening Session Suggest No Major Near-Term Changes?

The agency seeks feedback at a 13 June virtual hearing on three general topics related to advisory committees: panel composition, barriers to service for Special Government Employees, and public perception and understanding of the adcomm process.

Hearing
The FDA is holding a listening session on several aspects of the adcomm process. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers